These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 3996238)

  • 1. [Therapy of hyperprolactinemia].
    Schatz H
    Dtsch Med Wochenschr; 1985 Jun; 110(24):964-6. PubMed ID: 3996238
    [No Abstract]   [Full Text] [Related]  

  • 2. The pathophysiology of hyperprolactinemic states and the role of newer ergot compounds in their treatment.
    Frantz AG; Kleinberg DL
    Fed Proc; 1978 Jun; 37(8):2192-7. PubMed ID: 26606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ergot drugs in the treatment of endocrine disorders: introduction.
    Kleinberg DL; Frantz AG
    Adv Biochem Psychopharmacol; 1980; 23():143-6. PubMed ID: 7395608
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical disorders of pituitary and thyroid hyperfunction.
    Schuster LD
    Minn Med; 1980 Jul; 63(7):459-66. PubMed ID: 7402182
    [No Abstract]   [Full Text] [Related]  

  • 5. [The therapy of hyperprolactinemia].
    von Werder K
    Dtsch Med Wochenschr; 1992 Dec; 117(51-52):1967-70. PubMed ID: 1362148
    [No Abstract]   [Full Text] [Related]  

  • 6. Hyperprolactinemia.
    Kemmann E; Jones JR
    Am Fam Physician; 1981 Mar; 23(3):119-24. PubMed ID: 7468401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hyperprolactinemia in women].
    Kubista E
    Wien Med Wochenschr; 1983 Aug; 133(15-16):387-92. PubMed ID: 6685407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dopaminergic ergot combinations. A new therapeutic principle].
    von Werder K
    MMW Munch Med Wochenschr; 1983 Jun; 125(23):489-91. PubMed ID: 6410211
    [No Abstract]   [Full Text] [Related]  

  • 9. [Bromocryptin in the treatment of amenorrheas with hyperprolactinemia].
    Anselmo J
    Rev Chil Obstet Ginecol; 1977; 42(4):248-55. PubMed ID: 616619
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hyperprolactinemia. Pathophysiology, clinical significance, therapy].
    Von Werder K; Fahlbusch R; Rjosk HK
    Internist (Berl); 1977 Oct; 18(10):520-8. PubMed ID: 338540
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of non-puerperal galactorrhoea with an ergot alkaloid.
    Lutterbeck PM; Pryor JS; Varga L; Wenner R
    Br Med J; 1971 Jul; 3(5768):228-9. PubMed ID: 5105219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of pituitary tumor growth and function by ergot alkaloids.
    MacLeod RM; Lehmeyer JE
    Cancer Res; 1973 Apr; 33(4):849-55. PubMed ID: 4348776
    [No Abstract]   [Full Text] [Related]  

  • 13. Primary hypothyroidism with reversible hyperprolactinemia and pituitary enlargement.
    Powers JM; Block MB
    Ariz Med; 1980 Apr; 37(4):256-8. PubMed ID: 7369883
    [No Abstract]   [Full Text] [Related]  

  • 14. [Diagnosis of hyperprolactinemia].
    Schatz H
    Dtsch Med Wochenschr; 1985 Jun; 110(24):962-3. PubMed ID: 4039652
    [No Abstract]   [Full Text] [Related]  

  • 15. [Evaluation of 55 cases of hyperprolactinemia].
    Ricciardi I; Candido R; Festa B; Messalli E; Rampone N; Tolotti M; Torella M
    Arch Ostet Ginecol; 1980; 85(3):91-101. PubMed ID: 7199905
    [No Abstract]   [Full Text] [Related]  

  • 16. Pituitary apoplexy following chlorpromazine stimulation.
    Silverman VE; Boyd AE; McCrary JA; Kohler PO
    Arch Intern Med; 1978 Nov; 138(11):1738-9. PubMed ID: 718334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infertility in patients with hyperprolactinemia from a pituitary adenoma. Effect of transsphenoidal pituitary adenectomy.
    Dolman LI; Roberts TS; Poulson M; Tyler FH
    Arch Intern Med; 1977 Sep; 137(9):1161-4. PubMed ID: 901084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperprolactinemia and delayed puberty: a report of three cases and their response to therapy.
    Patton ML; Woolf PD
    Pediatrics; 1983 Apr; 71(4):572-5. PubMed ID: 6835739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dopaminergic agents in the treatment of hyperprolactinemia].
    Mornex R; Hugues B
    J Pharmacol; 1983; 14 Suppl 3():81-103. PubMed ID: 6369001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Modern drug treatment of hyperprolactinemia].
    Rachev E; Spasov S
    Akush Ginekol (Sofiia); 1985; 24(6):81-4. PubMed ID: 3911788
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.